Combined Thrombectomy for Distal Medium Vessel Occlusion Stroke
584
about 3.7 years
18+
4 sites in GA, IA, OH +1
About this study
Researchers are testing whether endovascular thrombectomy, in addition to standard medical care, improves outcomes for people who have a stroke caused by a blockage in a small blood vessel in the brain. The trial will last for 1337 days and involve approximately 584 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Standard medical management
- 2.Use Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Secondary: All cause mortality, Brain tissue reperfusion evaluated by CT or MRI perfusion at 24 hours in both treatment groups (if available), Cost effectiveness analysis of endovascular thrombectomy vs standard medical therapy, Final infarct growth (FIV - baseline infarct on CTP or DWI) evaluated on CT or MRI at 3-5 days (if available), Final infarct volume (FIV) (FIV - baseline infarct on CTP or DWI) evaluated on CT or MRI at 24 hours (-2/+12 hours), Final infarct volume (FIV) and infarct growth (FIV - baseline infarct on CTP or DWI) evaluated on CT or MRI at 3-5 days (if available), Patient reported outcomes ( IADL), Patient reported outcomes ( MoCa)
Neurology